A history of the dissolution of retained choledocholithiasis

American Journal of Surgery

Volumn 180, Issue 2, 2000, Pages 86-98

  Kelly, Edward ^a,b   Williams, Jane D ^a   Organ Jr , Claude H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CALCIUM CHELATING AGENT; CHLOROFORM; ETHER; HEPARIN; LOCAL ANESTHETIC AGENT; MUCOLYTIC AGENT; OCTANOIN; SOLVENT; TERT BUTYL METHYL ETHER; TURPENTINE;

BILIARY TRACT SURGERY; CHOLANGITIS; CHOLEDOCHOTOMY; COMMON BILE DUCT STONE; DIARRHEA; ENDOSCOPIC SURGERY; FEVER; GALLSTONE; HISTORY OF MEDICINE; HUMAN; LAPAROSCOPIC SURGERY; LEUKOCYTOSIS; MEDICAL LITERATURE; NAUSEA; PANCREATITIS; PRIORITY JOURNAL; REVIEW; STONE DISSOLUTION;

EID: 0033810942     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00428-1     Document Type: Article

References (87)

1. Epidemiology and natural history of gallstone disease
2. The effect of monooctanoin on retained common duct stones
3. Nonoperative roentgenologic instrumentation technics of the postoperative biliary tract. Treatment of biliary stricture and retained stones
4. Complications of endoscopic biliary sphincterotomy
5. Common bile duct exploration; the place of laparoscopic cholecystectomy
6. Historical sketch of cholelithiasis
7. Percutaneous transhepatic dissolution of common bile duct stones
8. Review of 220 cases of residual biliary tract calculi treated without reoperation; an eight-year study
9. Dissolution of retained duct stones by perfusion with monooctanoin via a Teflon catheter introduced endoscopically
10. Dissolution of bile duct stones
11. Percutaneous cholecystolithotomy
12. Chemical treatment of stones in the biliary tree
13. Agents for gallstone dissolution
14. The problem of the retained common duct stone
15. Medical treatment of biliary duct stones; effect of ursodeoxycholic acid administration
16. The removal of gallstones
17. An evaluation of solutions for fragmentation and dissolution of gallstones and their effect on liver and ductal tissue
18. The value of turpentine in gallstone operations
19. Dissolving gallstones
20. The problem of retained common duct stones
21. The role of the gallbladder in the pathogenesis of cholesterol gallstones
22. New methods in gallstone surgery
23. The incidence of liver stones associated with cholelithiasis and its clinical significance
24. Ether treatment of gallstones impacted in the common duct
25. The method for dissolution of common duct stones remaining after operation
26. Hepatitis; a constant accompaniment of cholecystitis
27. Common and hepatic duct stones
28. Fragmentation and expulsion of a common duct stone into the duodenum by using ether and amyl nitrate
29. Injection of ether into the biliary tract as treatment for choledocholithiasis
30. Nonoperative management of remaining common duct stones
31. The effect of dehydrocholic acid upon biliary pressure and its clinical application
32. Solution of gallstones
33. Experimental studies on the solvent action of ether on gallstones
34. Conservation therapy of residual calculi following operations on the common duct
35. Ether flush treatment of retained post-operative common duct stones; local survey
36. Dissolution and flushing technics for removal of retained common duct stones
37. Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations
38. Cholelitholysis using methyl tertiary butyl ether
39. Fragmentation of dissolution of gallstones by chloroform
40. Chloroform instillation into the common bile duct
41. Studies of the zeta potential of cells and a silica particle in varying concentrations of albumin, calcium, sodium, plasma, and bile
42. Dissolution of retained bile duct stones using heparin
43. Heparin and gallstones
44. Current status of heparin dissolution of gallstones. Experimental and clinical observations
45. Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines
46. Common duct obstructions relieved by injections of topical anesthetic into T-tube
47. Two way T-tube for continuous perfusion of the biliary tree
48. Retained common duct stones; a new nonoperative technique for treatment
49. Retained biliary calculi; removal by a simple non-operative technique
50. Retained common bile duct calculi
51. Non-invasive treatment for retained common bile duct stones in patients with T tube in situ; saline washout after intravenous ceruletide
52. The use sodium salt of dehydrocholic acid (decholin) as a choleretic
53. Medical treatment of cholesterol gallstones by bile desaturating agents
54. The disappearance of gallstone shadows following the prolonged administration of bile salts
55. The physicochemical basis of cholesterol gallstone formation in man
56. The natural history of cholelithiasis; the National Cooperative Gallstone Study
57. The present position concerning gallstone dissolution
58. National Cooperative Gallstone Study; the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins
59. Dissolution of cholesterol gallstones by chenodeoxycholic acid
60. Intraductal mono-octanoin for the direct dissolution of bile duct stones; experience in 343 patients
61. More on chenodiol; continued treatment and prevention of recurrences
62. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment
63. Management of choledocholithiasis
64. The treatment of retained stones in the common bile duct with sodium cholate infusion
65. Dissolution of stones in the common bile duct with bile-salt solutions
66. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial
67. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones; a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid
68. Clinical experience with monooctanoin for dissolution of bile duct stones; an uncontrolled multicenter trial
69. Monooctanoin, a dissolution agent for retained cholesterol bile duct stones; physical properties and clinical application
70. Selection of patients for dissolution of retained common duct stones with mono-octanoin
71. Dissolution of cholesterol gallstones in vitro. Gallstone matrix content and diameter, not cholesterol content, predict gallstone dissolution in monooctanoin
72. Intraductal infusion of mono-octanoin; experience in 24 patients with retained common-duct stones
73. Treatment of retained common bile duct stones; a prospective controlled study comparing monooctanoin and heparin
74. Choledocholithiasis-in vivo stone dissolution using methyl tertiary butyl ether (MTBE)
75. Methyl tert butyl ether dissolution therapy for common bile duct stones
76. Dissolution of calcium bilirubinate and calcium carbonate debris remaining after methyl tert-butyl ether dissolution of cholesterol gallstones
77. Chemical dissolution of common bile duct stones
78. The use of d-limonene preparation as a dissolving agent of gallstones
79. Dissolution of bile duct stones by a hydrophilized glyceromonooctanoin-bile-acid-EDTA emulsion
80. Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones
81. Contact solvents for common bile duct stones. Study in an in vitro system
82. Biliary proteins and the nucleation defect in cholesterol cholelithiasis
83. Contact litholysis of common bile duct calculi. Study of 44 patients
84. Laparoscopic common bile duct exploration
85. Endoscopic mechanical lithotripsy of difficult common bile duct stones